Virbac: H1 net profit down 3%

(CercleFinance.com) - Virbac has reported a 3.
2% fall in net income, group share, to E75m for H1 2023, and a 0.6 point decline in the ratio of recurring operating income before amortisation of assets acquired through business combinations to sales to 18.4% at constant exchange rates.

At E610.5m, the animal health group's sales fell by 1%, but remained stable (+0.4%) at constant exchange rates, benefiting from price increases (estimated effect around +5%) which offset lower volumes.

Virbac confirms its 2023 guidance for LFL sales growth of between 0 and 4%, and an OIR margin before amortisation of assets acquired through acquisitions that should consolidate between 12% and 13% at constant exchange rates.


Copyright (c) 2023 CercleFinance.com. All rights reserved.